Heart Failure: A Companion to Braunwald's Heart Disease E-book

-

Livres
2385 pages
Lire un extrait
Obtenez un accès à la bibliothèque pour le consulter en ligne
En savoir plus

Description

Dr. Douglas L. Mann, one of the foremost experts in the field, presents the 2nd Edition of Heart Failure: A Companion to Braunwald’s Heart Disease. This completely reworked edition covers the scientific and clinical guidance you need to effectively manage your patients and captures the dramatic advances made in the field over the last five years. Now in full color, this edition features eleven new chapters, including advanced cardiac imaging techniques, use of biomarkers, cell-based therapies and tissue engineering, device therapies, and much more. 

  • Consult this title on your favorite e-reader, conduct rapid searches, and adjust font sizes for optimal readability. Compatible with Kindle®, nook®, and other popular devices.
  • Use this Braunwald’s companion as the definitive source to prepare for the ABIM’s new Heart Failure board exam.
  • Access the fully searchable contents of the book online at Expert Consult.
  • This edition includes 67 new authors, who are experts in the field of heart failure
  • Stay on the cutting edge with new chapters on:
    • The latest practice guidelines for medical and device therapy
    • Hemodynamic assessment of heart failure
    • Contemporary medical therapy for heart failure patients with reduced and preserved ejection fraction
    • Biomarkers in heart failure
    • Pulmonary hypertension
    • Management of co-morbidities in heart failure
    • Mechanical cardiac support devices

  • Get up to speed with the latest clinical trials, as well as how they have influenced current practice guidelines
  • Explore what’s changing in key areas such as basic mechanisms of heart failure, genetic screening, cell and gene therapies, pulmonary hypertension, heart failure prevention, co-morbid conditions, telemedicine/remote monitoring, and palliative care

Sujets

Livres
Savoirs
Medecine
Médecine
Editorial
Cardiac dysrhythmia
Functional disorder
Atrial fibrillation
Myocardial infarction
Circulatory collapse
Diabetic cardiomyopathy
Cardiovascular magnetic resonance imaging
Tumor necrosis factors
Norepinephrine
Diastolic heart failure
Cognitive dysfunction
Milrinone
Carvedilol
Restrictive cardiomyopathy
Cardiomegaly
Dobutamine
Sideroblastic anemia
Valvular heart disease
Cell therapy
Stamina
Oxidative stress
Acute coronary syndrome
Nitrosation
Pharmacogenetics
Brain natriuretic peptide
Exercise intolerance
Guideline
Medical guideline
Candesartan
Lisinopril
Aortic valve replacement
Pharmacogenomics
Mitral regurgitation
Congenital heart defect
Metoprolol
Aortic insufficiency
Angiotensin-converting enzyme
Stroke
Renal function
Random sample
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Hypertrophy
Infarction
Coronary catheterization
Inhibitor
Review
Matrix metalloproteinase
Stiffness
Positive airway pressure
Myocarditis
Cardiac muscle
Weight loss
Programmed cell death
Conference
Echocardiography
Digoxin
Cachexia
Tissue engineering
Smoking cessation
Renin-angiotensin system
Ventricle (heart)
Renin
Immunosuppressive drug
Heart failure
Clinical trial
Cochlear implant
Warfarin
Dyspnea
General practitioner
Coronary artery bypass surgery
Sympathetic nervous system
Parasympathetic nervous system
Physical exercise
Thrombosis
Diabetes mellitus type 2
Defibrillation
Adenosine monophosphate
Atherosclerosis
Hypertension
Electrocardiography
Heart disease
Epidemiology
Ischaemic heart disease
Cardiac arrest
Obesity
Cardiomyopathy
Diabetes mellitus
Nervous system
Magnetism
Mechanics
Judaism
Genetic
Fatty acid
Endocarditis
Diuretic
Diet
Major depressive disorder
Cardiology
Énalapril
Necrosis
Amiodarone
Aspirin
Format
Systole
Mentor
Fatigue
Diastole
Mutation
Cytokine
Death
Surface
Transcription
Copyright
Adénosine triphosphate
Glucose
France

Informations

Publié par
Date de parution 11 novembre 2010
Nombre de lectures 0
EAN13 9781437703634
Langue English
Poids de l'ouvrage 13 Mo

Informations légales : prix de location à la page 0,0655€. Cette information est donnée uniquement à titre indicatif conformément à la législation en vigueur.

Signaler un problème






















! "








! "
"#!
$"% ! &
''! (!







! "#$%#% # & %'() (
"#%( (#% &%! *+,---,*-
".
/0
1 2. 3
4

5 6
7 66
/0


3
%

5
0 267
4. 2

373

4

3 . 5
4

2. . 4 67
7
47076 763/ 0
7./
7
3/

. 5
4

/ 3

6 .
4 8
0

4 8

/ 5
4

0 260
(
6 08
9
4 5

0
5
4
2

0
$260
:
4 67 3

/4
8
0
/;
70

0 ".
/0
"6
7 "

3
0 ".
/0
7/ /7. 7 2 53


82
!8886
74<
4
0 29 3
0 336 7
2
7
3

7
3 3

7.
/0
2.
0 $260
=
0

0 4. 2
3 0
>


?863/ 3 2

7
7
0 @63
7

6. 70// 8


70 3 A
7 2
3
3

3/ 70/

70
4
03
56
7
7
4376

4
4. 274 7
.
$
7


3

70
4
68.
6.
0
8 A
7 3
9863/ 6
/ 3 / . 5
4
4
03 743

A
4
37
23 0
/ 70 5
4

4
03
0. 063
2 4356 5
0
8 5
. 3
0 5
. 5
0
763/

5

804
0. 0
56
26
.
'
0
7

. 3
/
0
47
76
37
3
@3
3


33
7079
0 4
7


5
4

33 =>
73

5

3
=> 2.
0 457


5 70
37

2 34

3

5.

0
74433 3
5
46
0 4
03 3 3

5 34


3 7
37


0
26
. 5
7



6./
0

8 A
7 3 9863/ 5
0



49 3/
3

4
3/ 3
0 2


4
5
70 336

3

9 66



5
.
7


0 566
A

5
0 68
0

0 $260


0
0

7
2


3

4 . 626
. 5
. B
. 3<
34/




. 4


5
37
626
. /6/7

0
8

5
4 .


5 . 4
03
37

7

3
7
3
0 4

6 0

2

. 5 "/
"
6//--$267
(

56
! 74
&
863: 0

3 < C3
3 2.D
(/6 -- 3 3
E 74
"4
! &
863: 0

3 < 3
3 2. $

22. F C
6D ,
0 3 7,
763 226/
076
5
7 3 3A
&% *+,---,*-

56
(/6 &
863: 0

3
C(%!

6
'G + , D
","
)--37 ,


%
0 3B697
&
3 768



"
0
H79

H9
?4





$

3
3

5 4
7

3/

0

42
! * , +













































!"
#"





$

%



&
& %

' "

!$ ()*+





, &
!

-






"



*
$




.


- /
0 1
,

0

$
'$
$

$ '















0

23
&
&



0




!" 0
$

4 $
&" #

-







" 0


-